Please assess the completion status of the following clinical trial:

Trial Title: Improving Knowledge in Heart Failure Inpatient With Therapeutic Education

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hospitalization in the Department of General Internal Medicine or Cardiology for decompensated heart failure with lowered left ventricular ejection fraction (LVEF) (≤40%) from any cause or mildly lowered LVEF (41-49%) with the presence of heart failure-specific drug therapy~* Stability of the patient's clinical condition~* ≥ 2 heart failure medications~* ≥18 years~* Full capacity of discernment~* Absence of cognitive impairment~* Ability to speak, understand and read in French~* Get a personal telephone~* Consent form signed by the participant~Exclusion Criteria:~* Inability to follow study procedures~* Institutionalized persons~* Asylum seekers, homeless people, prisoners~* Incapacity of judgment and discernment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Patient therapeutic education group (Type: EXPERIMENTAL): The intervention group will benefit from a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients and usual hospital care (medical and nursing care)
- Usual hospital care group (Type: NO_INTERVENTION): The control group do only benefit from the usual hospital care (any medical and nursing care giving to an acute heart failure inpatient) and won't benefit from the pharmacist's educational intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).